Latest Insider Transactions at Miromatrix Medical Inc. (MIRO)
This section provides a real-time view of insider transactions for Miromatrix Medical Inc. (MIRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Miromatrix Medical Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Miromatrix Medical Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Peter Maag |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,368
-100.0%
|
-
|
|
Dec 13
2023
|
Lisa Wipperman Heine |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,413
-100.0%
|
-
|
|
Dec 13
2023
|
James Michael Douglas CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,000
-100.0%
|
-
|
|
Dec 13
2023
|
William P. Burke Mr. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,413
-100.0%
|
-
|
|
Dec 13
2023
|
Paul Buckman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
54,201
-100.0%
|
-
|
|
Dec 13
2023
|
John L Erb |
SELL
Sale (or disposition) back to the issuer
|
Direct |
54,201
-100.0%
|
-
|
|
Dec 13
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
87,500
-100.0%
|
-
|
|
Dec 12
2023
|
Peter Maag |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
62,092
-51.55%
|
-
|
|
Dec 12
2023
|
Lisa Wipperman Heine |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
66,943
-49.83%
|
-
|
|
Dec 12
2023
|
James Michael Douglas CHIEF FINANCIAL OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
31,250
-60.98%
|
-
|
|
Dec 12
2023
|
William P. Burke Mr. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
66,943
-49.83%
|
-
|
|
Dec 12
2023
|
Paul Buckman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
52,593
-49.25%
|
-
|
|
Dec 12
2023
|
John L Erb |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
56,260
-50.93%
|
-
|
|
Dec 12
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
308,775
-77.92%
|
-
|
|
Jun 01
2023
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
54,201
+28.75%
|
-
|
|
Jun 01
2023
|
William P. Burke Mr. |
BUY
Grant, award, or other acquisition
|
Direct |
54,201
+28.75%
|
-
|
|
Jun 01
2023
|
John L Erb |
BUY
Grant, award, or other acquisition
|
Direct |
54,201
+32.92%
|
-
|
|
Jun 01
2023
|
Peter Maag |
BUY
Grant, award, or other acquisition
|
Direct |
54,201
+31.03%
|
-
|
|
Jun 01
2023
|
Paul Buckman |
BUY
Grant, award, or other acquisition
|
Indirect |
54,201
+33.67%
|
-
|
|
Mar 10
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
31,250
+7.31%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
James Michael Douglas CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
31,250
+37.88%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
Lisa Wipperman Heine |
BUY
Open market or private purchase
|
Direct |
31,250
+28.05%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
William P. Burke Mr. |
BUY
Open market or private purchase
|
Direct |
31,250
+28.05%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
John L Erb |
BUY
Open market or private purchase
|
Direct |
31,250
+35.71%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
Peter Maag |
BUY
Open market or private purchase
|
Direct |
31,250
+32.05%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
Paul Buckman |
BUY
Open market or private purchase
|
Indirect |
31,250
+37.27%
|
$31,250
$1.6 P/Share
|
|
Mar 10
2023
|
John Joseph Barry VICE PRESIDENT OF R&D |
BUY
Open market or private purchase
|
Direct |
6,250
+14.98%
|
$6,250
$1.6 P/Share
|
|
Jan 13
2023
|
James Michael Douglas CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Jan 13
2023
|
John Joseph Barry VICE PRESIDENT OF R&D |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+25.49%
|
-
|
|
Jan 13
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,487
-1.21%
|
$13,461
$3.26 P/Share
|
|
Jan 13
2023
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.92%
|
-
|
|
Dec 06
2022
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,575
-3.5%
|
$46,300
$4.05 P/Share
|
|
Dec 06
2022
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+10.17%
|
$37,500
$1.25 P/Share
|
|
Oct 01
2022
|
John Joseph Barry VICE PRESIDENT OF R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
765
-3.83%
|
$3,060
$4.38 P/Share
|
|
Aug 10
2022
|
Peter Maag |
BUY
Grant, award, or other acquisition
|
Direct |
12,788
+26.75%
|
-
|
|
Aug 10
2022
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
12,788
+20.73%
|
-
|
|
Aug 10
2022
|
John L Erb |
BUY
Grant, award, or other acquisition
|
Direct |
12,788
+33.83%
|
-
|
|
Aug 10
2022
|
William P. Burke Mr. |
BUY
Grant, award, or other acquisition
|
Direct |
12,788
+20.73%
|
-
|
|
Aug 10
2022
|
Paul Buckman |
BUY
Grant, award, or other acquisition
|
Indirect |
12,788
+37.47%
|
-
|
|
Mar 15
2022
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
35,438
+10.77%
|
$35,438
$1.25 P/Share
|
|
Jan 13
2022
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+16.23%
|
-
|
|
Jan 13
2022
|
Laji Kattungal VICE PRESIDENT OF QUALITY |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 13
2022
|
John Joseph Barry VICE PRESIDENT OF R&D |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+33.33%
|
-
|
|
Jan 13
2022
|
Brian Niebur CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+28.85%
|
-
|
|
Jan 03
2022
|
William P. Burke Mr. |
BUY
Grant, award, or other acquisition
|
Direct |
36,117
+48.38%
|
-
|
|
Jan 03
2022
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
36,117
+48.38%
|
-
|
|
Oct 01
2021
|
John Joseph Barry VICE PRESIDENT OF R&D |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 01
2021
|
Brian Niebur CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+35.29%
|
-
|
|
Jun 28
2021
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Conversion of derivative security
|
Direct |
4,400
+50.0%
|
-
|
|
Jun 28
2021
|
Brian Niebur CHIEF FINANCIAL OFFICER |
BUY
Conversion of derivative security
|
Direct |
6,668
+41.67%
|
-
|